China Regenerative Medicine International Limited announced the resignation of Mr. Wang Xuejun as a chief executive officer of the Company effect from July 9, 2020, due to his decision to focus his time and effort on his other business. Following the resignation of Mr. Wang, the Board further announces that Mr. Wang Chuang be appointed as the Chief Executive officer with effect from 9 July 2020. Mr. Wang Chuang, aged 40, was appointed as an executive Director and chairman of the Board with effect from 18 October 2019. He was accredited as a grade 1 health management professional by the Hubei Provincial Department of Human Resources and Social Security of China in May 2016 and a psychological consultant by the Ministry of Human Resources and Social Security of China in March 2019.